StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Extreme Dissapointement in Botched Launch

<< Previous

Bullboard Posts

Next >>

Comment by johnny007on Apr 09, 2021 6:31pm

114 Views

Post# 32971442

RE:RE:RE:Extreme Dissapointement in Botched Launch

Looking around their newly named 'SEEK Group', they are in a 'searching mission'.

Interestingly, they dropped the name 'Health Clinics Limited'
also having a new address.
This probably due to the current asset offloading to SZLS
with the Care Oncology Clinic "COC" portion.

Lots of question, but whats new with SZLS right?
We remember Oncore and all the other 'stuff' going.

Yes, this story fascinates me.

<< Previous

Bullboard Posts

Next >>

Buzz on the Bullboards: Stocks to watch in volatile times.